A Jarde1, O Lutsiv1, C K Park2, J Beyene2, J M Dodd3, J Barrett4, P S Shah5, J L Cook6,7, S Saito8, A B Biringer9, L Sabatino10, L Giglia11, Z Han12, K Staub13, W Mundle14, J Chamberlain15, S D McDonald1. 1. Department of Obstetrics and Gynaecology, McMaster University, Hamilton, ON, Canada. 2. Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada. 3. Department of Obstetrics and Gynaecology, University of Adelaide, Adelaide, SA, Australia. 4. Sunnybrook Health Sciences Centre, Toronto, ON, Canada. 5. Department of Paediatrics, University of Toronto, Toronto, ON, Canada. 6. The Society of Obstetricians and Gynaecologists of Canada, Ottawa, ON, Canada. 7. Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, ON, Canada. 8. Department of Obstetrics and Gynaecology, University of Toyama, Toyama, Japan. 9. Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. 10. Midwifery Education Program, McMaster University, Hamilton, ON, Canada. 11. Department of Paediatrics, McMaster University, Hamilton, ON, Canada. 12. The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China. 13. Canadian Premature Babies Foundation, Sherwood Park, AB, Canada. 14. Maternal Fetal Medicine Clinic, Windsor Regional Hospital, Windsor, ON, Canada. 15. Save the Mothers, Uganda Christian University, Mukono, Uganda.
Abstract
BACKGROUND: Preterm birth (PTB) is the leading cause of infant death, but it is unclear which intervention is best to prevent it. OBJECTIVES: To compare progesterone, cerclage and pessary, determine their relative effects and rank them. SEARCH STRATEGY: We searched Medline, EMBASE, CINAHL, Cochrane CENTRAL and Web of Science (to April 2016), without restrictions, and screened references of previous reviews. SELECTION CRITERIA: We included randomised trials of progesterone, cerclage or pessary for preventing PTB in women with singleton pregnancies at risk as defined by each study. DATA COLLECTION AND ANALYSIS: We extracted data by duplicate using a piloted form and performed Bayesian random-effects network meta-analyses and pairwise meta-analyses. We rated evidence quality using GRADE, ranked interventions using SUCRA and calculated numbers needed to treat (NNT). MAIN RESULTS: We included 36 trials (9425 women; 25 low risk of bias trials). Progesterone ranked first or second for most outcomes, reducing PTB < 34 weeks [odds ratio (OR) 0.44; 95% credible interval (CrI) 0.22-0.79; NNT 9; low quality], <37 weeks (OR 0.58; 95% CrI 0.41-0.79; NNT 9; moderate quality), and neonatal death (OR 0.50; 95% CrI 0.28-0.85; NNT 35; high quality), compared with control, in women overall at risk. We found similar results in the subgroup with previous PTB, but only a reduction of PTB < 34 weeks in women with a short cervix. Pessary showed inconsistent benefit and cerclage did not reduce PTB < 37 or <34 weeks. CONCLUSIONS: Progesterone was the best intervention for preventing PTB in singleton pregnancies at risk, reducing PTB < 34 weeks, <37 weeks, neonatal demise and other sequelae. TWEETABLE ABSTRACT: Progesterone was better than cerclage and pessary to prevent preterm birth, neonatal death and more in network meta-analysis.
BACKGROUND: Preterm birth (PTB) is the leading cause of infant death, but it is unclear which intervention is best to prevent it. OBJECTIVES: To compare progesterone, cerclage and pessary, determine their relative effects and rank them. SEARCH STRATEGY: We searched Medline, EMBASE, CINAHL, Cochrane CENTRAL and Web of Science (to April 2016), without restrictions, and screened references of previous reviews. SELECTION CRITERIA: We included randomised trials of progesterone, cerclage or pessary for preventing PTB in women with singleton pregnancies at risk as defined by each study. DATA COLLECTION AND ANALYSIS: We extracted data by duplicate using a piloted form and performed Bayesian random-effects network meta-analyses and pairwise meta-analyses. We rated evidence quality using GRADE, ranked interventions using SUCRA and calculated numbers needed to treat (NNT). MAIN RESULTS: We included 36 trials (9425 women; 25 low risk of bias trials). Progesterone ranked first or second for most outcomes, reducing PTB < 34 weeks [odds ratio (OR) 0.44; 95% credible interval (CrI) 0.22-0.79; NNT 9; low quality], <37 weeks (OR 0.58; 95% CrI 0.41-0.79; NNT 9; moderate quality), and neonatal death (OR 0.50; 95% CrI 0.28-0.85; NNT 35; high quality), compared with control, in women overall at risk. We found similar results in the subgroup with previous PTB, but only a reduction of PTB < 34 weeks in women with a short cervix. Pessary showed inconsistent benefit and cerclage did not reduce PTB < 37 or <34 weeks. CONCLUSIONS: Progesterone was the best intervention for preventing PTB in singleton pregnancies at risk, reducing PTB < 34 weeks, <37 weeks, neonatal demise and other sequelae. TWEETABLE ABSTRACT: Progesterone was better than cerclage and pessary to prevent preterm birth, neonatal death and more in network meta-analysis.
Authors: Kaizhi Zheng; Ping Lu; Ellen Delpapa; Karl Bellve; Ruitang Deng; Jennifer C Condon; Kevin Fogarty; Lawrence M Lifshitz; Tiffany A Moore Simas; Fangxiong Shi; Ronghua ZhuGe Journal: FASEB J Date: 2017-05-30 Impact factor: 5.191
Authors: Laura L Jelliffe-Pawlowski; Larry Rand; Bruce Bedell; Rebecca J Baer; Scott P Oltman; Mary E Norton; Gary M Shaw; David K Stevenson; Jeffrey C Murray; Kelli K Ryckman Journal: J Perinatol Date: 2018-05-24 Impact factor: 3.225
Authors: Tinu M Samuel; Olga Sakwinska; Kimmo Makinen; Graham C Burdge; Keith M Godfrey; Irma Silva-Zolezzi Journal: Nutrients Date: 2019-08-06 Impact factor: 5.717
Authors: Renato T Souza; Elizabeth J McKenzie; Beatrix Jones; Jamie V de Seymour; Melinda M Thomas; Erica Zarate; Ting Li Han; Lesley McCowan; Karolina Sulek; Silas Villas-Boas; Louise C Kenny; José G Cecatti; Philip N Baker Journal: Sci Rep Date: 2019-09-23 Impact factor: 4.379